Relay Therapeutics To Present Initial Clinical Results, Preclinical Data For Zovegalisib In Vascular Anomalies At International Society For The Study Of Vascular Anomalies World Congress 2026

Relay Therapeutics, Inc. (NASDAQ: RLAY) will present initial clinical results and preclinical data for zovegalisib (RLY-2608) targeting vascular anomalies at the ISSVA World Congress 2026, scheduled for May 19-22, 2026, in Philadelphia. The company expects to report clinical data on around 20 efficacy-evaluable patients.